Corcept Therapeutics, Inc. (CORT)
40.20
-0.77
(-1.88%)
USD |
NASDAQ |
Feb 11, 11:06
Corcept Therapeutics Market Cap : 4.229B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Axsome Therapeutics, Inc. | 9.177B |
| Johnson & Johnson | 578.83B |
| United Therapeutics Corp. | 20.15B |
| Harrow, Inc. | 1.740B |
| Ultragenyx Pharmaceutical, Inc. | 2.259B |
Market Cap Related Metrics
| PE Ratio | 45.93 |
| PS Ratio | 6.484 |
| Price to Book Value | 6.692 |
| Price to Free Cash Flow | 29.56 |
| Price | 40.20 |
| Earnings Yield | 2.18% |
| Operating PE Ratio | 73.29 |
| Normalized PE Ratio | 45.93 |